A MULTICENTER, OPEN-LABEL, RANDOMIZED, ACTIVE COMPARATOR STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF LACOSAMIDE IN NEONATES WITH REPEATED ELECTROENCEPHALOGRAPHIC NEONATAL SEIZURES

Administered By

Awarded By

Contributors

Start/End

  • September 21, 2020 - October 3, 2022